Brookfield Asset Management Inc. Moderna, Inc. Transaction History

Brookfield Asset Management Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Sep 25, 2023	BUY	$135.66 - $197.02 $5.48 Million - $7.95 Million	40,368 New	40,368 $6.2 Million
Q1 2023 May 15, 2023	BUY	$135.66 - $197.02 $1.7 Million - $2.47 Million	12,521 Added 44.96%	40,368 $6.2 Million
Q4 2022 Feb 14, 2023	BUY	$118.38 - $210.04 $2.06 Million - $3.65 Million	17,371 Added 165.82%	27,847 $5 Million
Q3 2022 Nov 14, 2022	BUY	$118.07 - $194.18 $1.24 Million - $2.03 Million	10,476 New	10,476 $1.24 Million
Q4 2021 Feb 14, 2022	BUY	$225.82 - $368.51 $1.05 Million - $1.71 Million	4,630 Added 178.97%	7,217 $1.83 Million
Q3 2021 Nov 16, 2021	SELL	$221.9 - $484.47 $202,372 - $441,836	-912 Reduced 26.06%	2,587 $995,000
Q2 2021 Aug 17, 2021	BUY	$129.91 - $234.98 $454,555 - $822,195	3,499 New	3,499 $822,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Brookfield Asset Management Inc., based on Form 13F filings with the SEC.

Stay updated on Brookfield Asset Management Inc. with notifications on news.